[1]
|
Dosage Forms, Formulation Developments and Regulations
2024
DOI:10.1016/B978-0-323-91817-6.00007-3
|
|
|
[2]
|
Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation
Advances in Pharmacological and Pharmaceutical Sciences,
2024
DOI:10.1155/2024/5583526
|
|
|
[3]
|
Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics
Journal of Pharmaceutical Sciences,
2023
DOI:10.1016/j.xphs.2023.08.003
|
|
|
[4]
|
Influence of Crystal Disorder on the Forced Oxidative Degradation of Vortioxetine HBr
AAPS PharmSciTech,
2023
DOI:10.1208/s12249-023-02721-6
|
|
|
[5]
|
Oxidative Stress
2023
DOI:10.1016/B978-0-323-91890-9.00029-5
|
|
|
[6]
|
About Analytical and Technological Reasons of Out-of-Specification Results for Assay and Disolution Tests (Review)
Drug development & registration,
2023
DOI:10.33380/2305-2066-2023-12-1-227-236
|
|
|
[7]
|
Oxidative degradation in pharmaceuticals: Mechanism and stabilization of a spray-dried amorphous drug – A case study
Journal of Pharmaceutical and Biomedical Analysis,
2022
DOI:10.1016/j.jpba.2022.114962
|
|
|
[8]
|
Features of the Development of Reference Materials of Pharmaceutical Substances
Measurement Techniques,
2022
DOI:10.1007/s11018-023-02140-w
|
|
|
[9]
|
Understanding and evaluation of different degradation pathways and stability of drug product with active substance prone to chemical and physical degradation
Macedonian Pharmaceutical Bulletin,
2022
DOI:10.33320/maced.pharm.bull.2022.68.03.037
|
|
|
[10]
|
Monitoring of the natural aging of Diclofenac tablets, NIR and MIR-ATR spectroscopy coupled with chemometrics data analysis
Journal of Pharmaceutical and Biomedical Analysis,
2022
DOI:10.1016/j.jpba.2022.114917
|
|
|
[11]
|
Oxidation of Drugs during Drug Product Development: Problems and Solutions
Pharmaceutics,
2022
DOI:10.3390/pharmaceutics14020325
|
|
|
[12]
|
The Identification of Quality Risk Factors for Non-biological Complex Drugs and Epilepsy Drugs Using Statistical Analysis of Formulation-Based Recalls in the USA
AAPS PharmSciTech,
2022
DOI:10.1208/s12249-021-02165-w
|
|
|
[13]
|
Biolubricant production via esterification and transesterification processes: Current updates and perspectives
International Journal of Energy Research,
2022
DOI:10.1002/er.7453
|
|
|
[14]
|
Drug Carriers: A Review on the Most Used Mathematical Models for Drug Release
Processes,
2022
DOI:10.3390/pr10061094
|
|
|
[15]
|
Directly compressible formulation of immediate release rosuvastatin calcium tablets stabilized with tribasic calcium phosphate
Pharmaceutical Development and Technology,
2022
DOI:10.1080/10837450.2022.2073370
|
|
|
[16]
|
The Degradation Map Process – A Tool for Obtaining a Lean Stability Strategy in Drug Development
Journal of Pharmaceutical Sciences,
2022
DOI:10.1016/j.xphs.2021.12.015
|
|
|
[17]
|
DSC, FT-IR and NIR with Chemometric Assessment Using PCA and HCA for Estimation of the Chemical Stability of Oral Antidiabetic Drug Linagliptin in the Presence of Pharmaceutical Excipients
Molecules,
2022
DOI:10.3390/molecules27134283
|
|
|
[18]
|
Assessing compatibility of excipients selected for a sustained release formulation of bilberry leaf extract
Brazilian Journal of Pharmaceutical Sciences,
2022
DOI:10.1590/s2175-97902022e19753
|
|
|
[19]
|
Oxidative degradation in pharmaceuticals: Mechanism and stabilization of a spray-dried amorphous drug – A case study
Journal of Pharmaceutical and Biomedical Analysis,
2022
DOI:10.1016/j.jpba.2022.114962
|
|
|
[20]
|
Monitoring of the natural aging of Diclofenac tablets, NIR and MIR-ATR spectroscopy coupled with chemometrics data analysis
Journal of Pharmaceutical and Biomedical Analysis,
2022
DOI:10.1016/j.jpba.2022.114917
|
|
|
[21]
|
A Simple Non-Linear Kinetic Model to Evaluate Stability of a Pressure Sensitive Drug
Journal of Pharmaceutical Sciences,
2022
DOI:10.1016/j.xphs.2022.07.010
|
|
|
[22]
|
Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA)
Molecules,
2021
DOI:10.3390/molecules26185632
|
|
|
[23]
|
Improving Robustness of Pharmaceutical Dosage form Sample Preparation Using Experimental Design and Process Understanding Tools
Chromatographia,
2020
DOI:10.1007/s10337-020-03969-x
|
|
|
[24]
|
Screening and preparation of quercetin doped nanoemulsion: characterizations, antioxidant and anti-bacterial activities
LWT,
2020
DOI:10.1016/j.lwt.2020.109141
|
|
|
[25]
|
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing
AAPS PharmSciTech,
2020
DOI:10.1208/s12249-020-01854-2
|
|
|
[26]
|
Study on the Mechanism Responsible for the Incompatibility of Enalapril Maleate with Sodium Starch Glycolate
Journal of Pharmaceutical Sciences,
2020
DOI:10.1016/j.xphs.2020.11.037
|
|
|
[27]
|
Determination of chemical stability of sitagliptin by LC-UV, LC-MS and FT-IR methods
Journal of Pharmaceutical and Biomedical Analysis,
2019
DOI:10.1016/j.jpba.2018.11.023
|
|
|
[28]
|
Quality Control [Working Title]
2019
DOI:10.5772/intechopen.83849
|
|
|
[29]
|
Effect of intra- and extragranular addition of highly porous tribasic calcium phosphate on properties of immediate release acyclovir formulation – Comparison with commercial tablets using compendial and biorelevant dissolution methods
Journal of Drug Delivery Science and Technology,
2019
DOI:10.1016/j.jddst.2019.03.013
|
|
|
[30]
|
The Degradation Chemistry of GSK2879552: Salt Selection and Microenvironmental pH Modulation to Stabilize a Cyclopropyl Amine
Journal of Pharmaceutical Sciences,
2019
DOI:10.1016/j.xphs.2019.04.026
|
|
|
[31]
|
Identification of an Adduct Impurity of an Active Pharmaceutical Ingredient and a Leachable in an Ophthalmic Drug Product Using LC-QTOF
Journal of Pharmaceutical Sciences,
2019
DOI:10.1016/j.xphs.2019.06.009
|
|
|
[32]
|
In
‐vitro
cytotoxicity of various
Siphonochilus aethiopicus
(Schweinf.) B.L. Burtt extracts in combination with selected tableting excipients
Journal of Pharmacy and Pharmacology,
2019
DOI:10.1111/jphp.13160
|
|
|
[33]
|
Innovative Dosage Forms
Methods and Principles in Medicinal Chemistry,
2019
DOI:10.1002/9783527812172.ch3
|
|
|
[34]
|
Application of Failure Mode Effect Analysis in Wurster-Based Pelletization Technology: a Technical Note
AAPS PharmSciTech,
2019
DOI:10.1208/s12249-019-1516-7
|
|
|
[35]
|
Innovative Dosage Forms
Methods and Principles in Medicinal Chemistry,
2019
DOI:10.1002/9783527812172.ch3
|
|
|
[36]
|
Compatibility of Medicinal and Excipient Substances in the Development of Medicinal Formulations
Pharmaceutical Chemistry Journal,
2018
DOI:10.1007/s11094-018-1876-4
|
|
|
[37]
|
Technical challenges in obtaining an optimized powder/DPI combination for inhalation delivery of a bi-component generic drug
Journal of Drug Delivery Science and Technology,
2018
DOI:10.1016/j.jddst.2018.01.019
|
|
|
[38]
|
A Robust Static Headspace GC-FID Method to Detect and Quantify Formaldehyde Impurity in Pharmaceutical Excipients
Journal of Analytical Methods in Chemistry,
2018
DOI:10.1155/2018/4526396
|
|
|
[39]
|
Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics
Drug Development and Industrial Pharmacy,
2018
DOI:10.1080/03639045.2018.1483392
|
|
|
[40]
|
Dosage Form Design Parameters
2018
DOI:10.1016/B978-0-12-814421-3.00011-7
|
|
|
[41]
|
DSC, FT-IR, NIR, NIR-PCA and NIR-ANOVA for determination of chemical stability of diuretic drugs: impact of excipients
Open Chemistry,
2018
DOI:10.1515/chem-2018-0014
|
|
|
[42]
|
Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC
AAPS PharmSciTech,
2017
DOI:10.1208/s12249-017-0716-2
|
|
|
[43]
|
Incompatibility of Paracetamol with Pediatric Suspensions Containing Amoxicillin, Azithromycin and Cefuroxime Axetil
Pharmacology & Pharmacy,
2017
DOI:10.4236/pp.2017.811026
|
|
|
[44]
|
Stability testing of drug eluting stents
Journal of Drug Delivery Science and Technology,
2016
DOI:10.1016/j.jddst.2016.05.006
|
|
|